TY - JOUR
T1 - The presence of antibody-dependent cell cytotoxicity- mediating antibodies in kaposi sarcoma-associated herpesvirus-seropositive individuals does not correlate with disease pathogenesis or progression
AU - Poppe, Lisa K.
AU - Wood, Charles
AU - West, John T.
N1 - Funding Information:
This study is supported in part by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases under Ruth L. Kirschstein National Research Service Award T32 AI125207, as well as NIH Public Health Service Grants NCI75903, NCI U54CA221204, and D43TW010354 (to C.W.). L.K.P. is a Ruth L. Kirchstein fellow.
Publisher Copyright:
Copyright © 2020 by The American Association of Immunologists, Inc.
PY - 2020/11/15
Y1 - 2020/11/15
N2 - Although the immune response is likely to play a pivotal role in controlling Kaposi sarcoma (KS)-Associated herpesvirus (KSHV) and preventing disease development, the exact factors responsible for that control remain ill defined. T cell responses are weak and variable, and neutralizing Abs are more frequently detected in individuals with KS. This suggests a potential role for nonneutralizing Abs, which to date have been largely uninvestigated. Ab-dependent cell cytotoxicity (ADCC) is a common effector function for nonneutralizing Abs and is known to play a protective role in other herpesvirus infections; yet, ADCC has never been investigated in the context of KSHV infection. In this study, we provide, to our knowledge, the first evidence that anti-KSHV Abs are capable of mediating ADCC responses against infected human cells undergoing lytic reactivation. ADCC activity significantly higher than seronegative controls was detected in 24 of 68 KSHV-seropositive individuals tested. However, ADCC responses were not associated with KS development or progression. ADCC activity was also found to be independent of HIV status, sex, age, KSHVAb titer, and KSHV-neutralizing activity. Nevertheless, additional investigations into effector cell function between KS and asymptomatic individuals are needed to determine whether ADCC has a role in preventing KS.
AB - Although the immune response is likely to play a pivotal role in controlling Kaposi sarcoma (KS)-Associated herpesvirus (KSHV) and preventing disease development, the exact factors responsible for that control remain ill defined. T cell responses are weak and variable, and neutralizing Abs are more frequently detected in individuals with KS. This suggests a potential role for nonneutralizing Abs, which to date have been largely uninvestigated. Ab-dependent cell cytotoxicity (ADCC) is a common effector function for nonneutralizing Abs and is known to play a protective role in other herpesvirus infections; yet, ADCC has never been investigated in the context of KSHV infection. In this study, we provide, to our knowledge, the first evidence that anti-KSHV Abs are capable of mediating ADCC responses against infected human cells undergoing lytic reactivation. ADCC activity significantly higher than seronegative controls was detected in 24 of 68 KSHV-seropositive individuals tested. However, ADCC responses were not associated with KS development or progression. ADCC activity was also found to be independent of HIV status, sex, age, KSHVAb titer, and KSHV-neutralizing activity. Nevertheless, additional investigations into effector cell function between KS and asymptomatic individuals are needed to determine whether ADCC has a role in preventing KS.
UR - http://www.scopus.com/inward/record.url?scp=85095973468&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095973468&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.2000489
DO - 10.4049/jimmunol.2000489
M3 - Article
C2 - 32998986
AN - SCOPUS:85095973468
VL - 205
SP - 2742
EP - 2749
JO - Journal of Immunology
JF - Journal of Immunology
SN - 0022-1767
IS - 10
ER -